Company Analysis
Sign in

PharmaCyte Biotech, Inc. (PMCB)

Nasdaq: PMCB · Biological Products, (No Diagnostic Substances) · Las Vegas, NV · filing with the SEC since 2001
Full chart Alerts Compare
Grade4.8
◀ Past 7.0● Present 4.6▶ Future 3.7
4 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in April.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingApr 30, 2026Apr 30, 2025Apr 30, 2024Apr 30, 2023Apr 30, 2022Apr 30, 2021Apr 30, 2020Apr 30, 2019Apr 30, 2018Apr 30, 2017
Report filedJul 29, 2026Aug 11, 2025Aug 13, 2024Jul 31, 2023Jul 28, 2022Aug 10, 2021Aug 13, 2020Aug 13, 2019Jul 20, 2018Jul 27, 2017
Revenue0000000000
Research and development391,301438,416407,431468,536690,937916,249301,221460,0521,997,8111,182,251
General and administrative4,912,9853,939,4466,112,577r1,112,6771,090,347418,1451,162,5531,378,5441,818,923744,796
Total operating expenses6,853,7134,377,8628,520,0086,455,4944,392,0143,622,9813,826,3954,100,6296,981,4294,442,146
Operating income-6,853,713-4,377,862-8,520,008-6,455,494-4,392,014-3,622,981-3,826,395-4,100,629-6,981,429-4,442,146
Interest expense···05093,046453001,539
Interest and investment income733,3511,415,5613,398,8191,937,499157,6450····
Other income (expense), net-980-965191,145202,002-4,28371,745-49333,401152,588-1,539
Total non-operating income (expense)-12,570,94135,033,9128,853,7712,139,501152,85371,745····
Income tax expense0000000000
Net income-19,424,65430,656,050333,763-4,315,993-4,239,161-3,551,236-3,826,888-4,067,228-6,828,841-4,443,685
Net income to common shareholders-23,206,37223,362,107-17,237,403-4,315,993······
Earnings per share, basic-2.773.19-1.80-0.22-0.27-2.45····
Earnings per share, diluted-2.773.19-1.80-0.22-0.27-2.45····
Earnings per share, basic and diluted·····-2.45-4.23r0.00-0.01-0.01
Weighted average shares, basic8,378,2917,329,5969,581,05919,489,20415,521,6541,448,285903,812r1,100,104,338968,641,686845,308,413
Weighted average shares, diluted8,378,2917,329,5969,581,05919,489,20415,521,6541,448,285903,812r1,100,104,338968,641,686845,308,413
Weighted average shares, basic and diluted·····1,448,285903,812r1,100,104,338968,641,686845,308,413
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton PMCB · research, not advice